Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome-Reference-Cited by-同舟云学术

Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome

Published:2013-11-08 Issue:1 Volume:38 Page:65-72
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Zhang Ying-Ying,Zhou Xin,Ji Wen-Jie,Shi Rui,Lu Rui-Yi,Li Jin-Long,Yang Guo-Hong,Luo Tao,Zhang Jian-Qi,Zhao Ji-Hong,Jiang Tie-Min,Li Yu-Ming

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-013-1022-9.pdf

Reference41 articles.

1. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr et al (2012) ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 60:645–681. doi: 10.1016/j.jacc.2012.06.004

2. Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O’Gara PT, Stein CM (2010) ACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning”: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association. Circulation 122:537–557. doi: 10.1161/CIR.0b013e3181ee08ed

3. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT et al (2009) Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 360:354–362. doi: 10.1056/NEJMoa0809171

4. Shuldiner AR, O’Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB et al (2009) Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 302:849–857. doi: 10.1001/jama.2009.1232

5. Siller-Matula JM, Lang I, Christ G, Jilma B (2008) Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 52:1557–1563. doi: 10.1016/j.jacc.2008.07.055

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of genetic variations of 3′-UTR in clopidogrel pharmacokinetic-relevant genes with clopidogrel response in Han Chinese patients with coronary artery disease;European Journal of Pharmaceutical Sciences;2024-09

2. Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial;International Journal of Cardiology;2024-07

3. Pharmacogenomics in cardiovascular disease;Diagnostic Molecular Pathology;2024

4. Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y12 Inhibitors and Their Association with Platelet Function;Journal of Clinical Medicine;2023-12-22

5. Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential;Cardiovascular Diabetology;2023-09-25